MISTIE INTRACEREBRAL HEMORRHAGE TRIAL

Does faster clot removal give better patient outcomes in ICH?

115 Sites to Quality:
113
90 Sites to Activate:
51
500 Participants to Enroll:
62
  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form

MISTIE

30

Good news everyone! Inservice training slides are now available in the documents section under Training Files. These are specifically designed to give non-core team members at your site a quick but comprehensive overview of the trial. 

http://braininjuryoutcomes.com/mistie-documents/viewcategory/66 

218


The new MISTIE-III mobile application is now finished! It is currently available for download on the iPhone and Android devices and can also be accessed using this link: http://braininjuryoutcomes.com/mistie-mobile/web/mistie.php

 

    b2ap3_thumbnail_Screen-Shot-2014-12-02-at-12.08.59-PM.png                 b2ap3_thumbnail_SamJPEG.png

 

The MISTIE-III MOBILE APP has the following features:

  • A link to the VISION EDC
  • Important Phone Numbers
  • Surgical Review Checklist
  • Inclusion/Exclusion Criteria
  • Schedule of Evaluations
  • Protocol at a Glance
  • ABC/2 Calculator
  • Dosing Guidance
  • NIH Stroke Scale Calculator
  • Modified Rankin Assessment
  • Stability Decision-making
  • Prohibited Medications
  • Catheter Tract Algorithm

                                                 b2ap3_thumbnail_Screen-Shot-2014-12-02-at-12.09.28-PM.png

 

1078

The 12th Annual Neurocritical Care Society (NCS) Meeting will be held this year in Seattle on 11-14 September. There will be a comprehensive session on intracerebral hemorrhage, including reviews of exciting recent advances in the translational, epidemiological and clinical areas. 

Friday’s focus on ICH will provide cutting-edge science, clarity in the practice of complex clinical problems, and maybe even stir up a little controversy. Our MISTIE/CLEAR Lead Investigator, Dr. Daniel F. Hanley, will be speaking as well, on interventional treatment so you don't want to miss it. Click here for details.

419

In collaboration with the Johns Hopkins University School of Medicine Office of Continuing Medical Education, we now provide continuing medical education (CME) credits, specifically AMA PRA Category 1 Credit™, for completing the online MISTIE-III investigator training courses.   You may earn up to 9 hours, but you must take a specific set of courses. You must also be a registered user of this site.

977

We are delighted to report that the first patient has now enrolled in the MISTIE III intracerebral hemorrhage trial! In the race to be the first out-of-the-gate, the honor goes to Hartford Hospital.

Dr. Inam Kureshi and his team at Hartford enrolled patient #1 at 17:02 on 30-Dec-2013, marking the official start of the study period. Congratulations go out to the Hartford team which includes the coordinator, Sara Jasak, RN, and the neurointensivist, Dr. Robert Brown. This was the 12th patient to be screened at this site since the site was activated on 11-December. We are especially proud of how Sara Jasak has entered the clinical data in near real-time; just a few days into the acute treatment and we already have 54 final case form pages with no open queries! Way to go, Sara!

Continue reading

Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
 
24-Hr: (410) 736-1368

Site Locations

Click marker for details. Green = actively enrolling.